Alternative treatment strategies to accelerate the elimination of onchocerciasis
Open Access
- 19 February 2018
- journal article
- review article
- Published by Oxford University Press (OUP) in International Health
- Vol. 10 (suppl_1) , i40-i48
Abstract
The use of alternative (or complementary) treatment strategies (ATSs) i.e. differing from annual community-directed treatment with ivermectin (CDTI) is required in some African foci to eliminate onchocerciasis by 2025. ATSs include vector control, biannual or pluriannual CDTI, better timing of CDTI, community-directed treatment with combinations of currently available anthelminthics or new drugs, and ‘test-and-treat’ (TNT) strategies requiring diagnosis of infection and/or contraindications to treatment for decisions on who to treat with what regimen. Two TNT strategies can be considered. Loa-first TNT, designed for loiasis-endemic areas and currently being evaluated using a rapid test (LoaScope), consists of identifying individuals with levels of Loa microfilaremia associated with a risk of post-ivermectin severe adverse events to exclude them from ivermectin treatment and in treating the rest (usually >97%) of the population safely. Oncho-first TNT consists of testing community members for onchocerciasis before giving treatment (currently ivermectin or doxycycline) to those who are infected. The choice of the ATS depends on the prevalences and intensities of infection with Onchocerca volvulus and Loa loa and on the relative cost-effectiveness of the strategies for the given epidemiological situation. Modelling can help select the optimal strategies, but field evaluations to determine the relative cost-effectiveness are urgently needed.Keywords
This publication has 77 references indexed in Scilit:
- The Cost of Annual versus Biannual Community-Directed Treatment of Onchocerciasis with Ivermectin: Ghana as a Case StudyPLOS Neglected Tropical Diseases, 2013
- Extended Result Reading Window in Lateral Flow Tests Detecting Exposure to Onchocerca volvulus: A New Technology to Improve Epidemiological Surveillance ToolsPLOS ONE, 2013
- Proof-of-Principle of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: Final Results of a Study in Mali and SenegalPLOS Neglected Tropical Diseases, 2012
- Empowering communities in combating river blindness and the role of NGOs: case studies from Cameroon, Mali, Nigeria, and UgandaHealth Research Policy and Systems, 2012
- Repositioning of an existing drug for the neglected tropical disease OnchocerciasisProceedings of the National Academy of Sciences, 2010
- Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in CameroonParasites & Vectors, 2009
- Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasisCurrent Opinion in Infectious Diseases, 2008
- The Future of Onchocerciasis Control in AfricaPLOS Neglected Tropical Diseases, 2007
- Relationships between the prevalence and intensity of Loa loa infection in the Central province of CameroonPathogens and Global Health, 2001
- Albendazole in Human Loiasis: Results of a Double-Blind, Placebo-Controlled TrialThe Journal of Infectious Diseases, 1993